Dr. Lucy Rorke-Adams Reflects on 50 Years as Pioneering Neuropathologist
Published on
For some, having samples of Albert Einstein’s brain might be a lifetime high point. For Dr. Lucy Rorke-Adams, it’s one episode in a long and varied medical career.
Published on
For some, having samples of Albert Einstein’s brain might be a lifetime high point. For Dr. Lucy Rorke-Adams, it’s one episode in a long and varied medical career.
Published on
Experts from the Poison Control Center discuss the dangers of e-cigarettes and liquid nicotine exposure in this post on the Healthy Kids blog.
Published on
Using lithium and other drugs in cell and animal models, CHOP researchers may have broken a logjam in devising effective treatments for mitochondrial diseases.
Published on
When CHOP opens its doors at the new Buerger Center for Advanced Pediatric Care on Monday, July 27, it will herald a new era in how pediatric medical facilities care for patients and their families.
Published on
The Children’s Hospital of Philadelphia, authored by the Hospital’s President and Chief Executive Officer, Madeline Bell, contains more than 200 never-before-published vintage photographs and stories.
Published on
A new national network of centers committed to clinical research on food allergies will support high-quality expertise and services at CHOP.
Published on
A local salon hosted a day of free makeovers and pampering for patients with facial differences treated by CHOP’s Craniofacial Program.
Published on
CHOP researchers have discovered gene locations affecting bone strength in wrist bones, the most common site for fractures in children. Children who have those genetic variants may be at higher-than-average risk of wrist fractures, and could especially benefit from activities and diets that promote bone strength.
Published on
Experts from the Poison Control Center explain the dangers related to misuse of dextromethorphan (DXM), a common ingredient in cough medicine.
Published on
CHOP neuroblastoma researchers have detailed how cancer-driving mutations evolve during chemotherapy, and they aim to exploit this knowledge to design better treatments for children.